{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:02Z","timestamp":1794047462744,"version":"4.8.0"},"reference-count":15,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"7","license":[{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2023.284271","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T03:06:37Z","timestamp":1709175997000},"page":"2309-2315","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy of DYRK1A inhibitors in novel models of Down syndrome acute lymphoblastic leukemia"],"prefix":"10.3324","volume":"109","author":[{"given":"Shannon L.","family":"Carey-Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam H.","family":"Simad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunjal","family":"Panchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Aya-Bonilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Smolders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse D.","family":"Armitage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jette","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajla","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Oommen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouchka P.","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mercher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Crispino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kassiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Besson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Deau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence C.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi S.","family":"Kotecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Malinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,2,29]]},"reference":[{"key":"63715","doi-asserted-by":"crossref","unstructured":"Buitenkamp TD, Izraeli S, Zimmermann M. Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group. Blood. 2014; 123(1):70-77.","DOI":"10.1182\/blood-2013-06-509463"},{"key":"63716","doi-asserted-by":"crossref","unstructured":"Ceppi F, Stephens D, den Hollander BS. Clinical presentation and risk factors of serious infections in children with Down syndrome treated for acute lymphoblastic leukemia. Pediatr Blood Cancer. 2016; 63(11):1949-1953.","DOI":"10.1002\/pbc.26127"},{"key":"63717","doi-asserted-by":"crossref","unstructured":"Rabin KR, Devidas M, Chen Z. Outcomes in children, adolescents, and young adults with Down syndrome and ALL: a report from the Children\u2019s Oncology Group. J Clin Oncol. 2024; 42(2):218-227.","DOI":"10.1200\/JCO.23.00389"},{"key":"63718","doi-asserted-by":"crossref","unstructured":"Meyr F, Escherich G, Mann G. Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with Down syndrome. Br J Haematol. 2013; 162(1):98-106.","DOI":"10.1111\/bjh.12348"},{"key":"63719","doi-asserted-by":"crossref","unstructured":"Rafei H, Kantarjian HM, Jabbour EJ. Targeted therapy paves the way for the cure of acute lymphoblastic leukaemia. Br J Haematol. 2020; 188(2):207-223.","DOI":"10.1111\/bjh.16207"},{"key":"63720","doi-asserted-by":"crossref","unstructured":"Laurent AP, Siret A, Ignacimouttou C. Constitutive activation of RAS\/MAPK pathway cooperates with trisomy 21 and is therapeutically exploitable in Down syndrome B-cell leukemia. Clin Cancer Res. 2020; 26(13):3307-3318.","DOI":"10.1158\/1078-0432.CCR-19-3519"},{"key":"63721","doi-asserted-by":"crossref","unstructured":"Lane AA, Chapuy B, Lin CY. Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation. Nat Genet. 2014; 46(6):618-623.","DOI":"10.1038\/ng.2949"},{"key":"63722","doi-asserted-by":"crossref","unstructured":"Bhansali RS, Rammohan M, Lee P. DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3. J Clin Invest. 2021; 131(1):e135937.","DOI":"10.1172\/JCI135937"},{"key":"63723","doi-asserted-by":"crossref","unstructured":"Page EC, Heatley SL, Eadie LN. HMGN1 plays a significant role in CRLF2 driven Down Syndrome leukemia and provides a potential therapeutic target in this high-risk cohort. Oncogene. 2022; 41(6):797-808.","DOI":"10.1038\/s41388-021-02126-4"},{"key":"63724","doi-asserted-by":"crossref","unstructured":"Li Z, Chang TC, Junco JJ. Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia. Blood. 2023; 142(2):172-184.","DOI":"10.1182\/blood.2023019765"},{"key":"63725","doi-asserted-by":"crossref","unstructured":"O\u2019Doherty A, Ruf S, Mulligan C. An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes. Science. 2005; 309(5743):2033-2037.","DOI":"10.1126\/science.1114535"},{"key":"63726","doi-asserted-by":"crossref","unstructured":"Tahtouh T, Durieu E, Villiers B. Structure-activity relationship in the Leucettine family of kinase inhibitors. J Med Chem. 2022; 65(2):1396-1417.","DOI":"10.1021\/acs.jmedchem.1c01141"},{"key":"63727","doi-asserted-by":"crossref","unstructured":"Lindberg MF, Deau E, Miege F. Chemical, biochemical, cellular, and physiological characterization of Leucettinib-21, a Down syndrome and Alzheimer\u2019s disease drug candidate. J Med Chem. 2023; 66(23):15648-15670.","DOI":"10.1021\/acs.jmedchem.3c01888"},{"key":"63728","doi-asserted-by":"crossref","unstructured":"Zhou Q, Phoa AF, Abbassi RH. Structural optimization and pharmacological evaluation of inhibitors targeting dual-specificity tyrosine phosphorylation-regulated kinases (DYRK) and CDC-like kinases (CLK) in glioblastoma. J Med Chem. 2017; 60(5):2052-2070.","DOI":"10.1021\/acs.jmedchem.6b01840"},{"key":"63729","doi-asserted-by":"crossref","unstructured":"Laetsch TW, Maude SL, Balduzzi A. Tisagenlecleucel in pediatric and young adult patients with Down syndrome-associated relapsed\/refractory acute lymphoblastic leukemia. Leukemia. 2022; 36(6):1508-1515.","DOI":"10.1038\/s41375-022-01550-z"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.284271\/76719","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.284271\/77216","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11483\/76719","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:05:52Z","timestamp":1794045952000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2023.284271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,29]]},"references-count":15,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2023.284271","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,29]]}}}